Saccardo T, Roccuzzo G, Tessari N, Zampollo S, et al. Early real-life outcomes of dupilumab and mepolizumab in patients with uncontrolled primary diffuse type 2 chronic rhinosinusitis. Eur Arch Otorhinolaryngol 2025;282:6281-6290.
PMID: 41109883